SCHEMBL23258705

SCHEMBL23258705

C/C=C/C(=O)c1cccc(O)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNA7 P36544 2/20 0.58
▸ P4HB P07237 5/20 0.57
▸ NR1H4 Q96RI1 2/20 0.55
▸ ABCG2 Q9UNQ0 1/20 0.54
▸ CA12 O43570 1/20 0.53
▸ CA1 P00915 1/20 0.53
▸ CA2 P00918 1/20 0.53
▸ CA6 P23280 1/20 0.53
▸ CA9 Q16790 1/20 0.53
▸ USP2 O75604 1/20 0.53
▸ PARP1 P09874 1/20 0.52
▸ DPP4 P27487 1/20 0.49
▸ BCHE P06276 1/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ MAPT P10636 2/20 0.49
▸ NFKB1 P19838 2/20 0.49
▸ NFKB2 Q00653 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ RELA Q04206 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11038651 0.84 CA12 (0.57) CHRNA7P4HBNR1H4ABCG2CA12
SCHEMBL1348921 0.81 GPR52 (0.56) PARP1MEN1MAPTKMT2AALDH1A1
SCHEMBL11813977 0.81 GPR52 (0.56) PARP1MEN1MAPTKMT2AALDH1A1
SCHEMBL11813974 0.81 GPR52 (0.56) PARP1MEN1MAPTKMT2AALDH1A1
SCHEMBL5646420 0.80 MAPT (0.69) CHRNA7P4HBNR1H4BCHEMAPT
SCHEMBL5646424 0.80 MAPT (0.69) CHRNA7P4HBNR1H4BCHEMAPT
SCHEMBL14416843 0.79 SNCA (0.53) CA12CA1CA2CA9MEN1
SCHEMBL29273761 0.79 ALDH1A1 (0.68) CHRNA7PARP1MEN1MAPTKMT2A
SCHEMBL29273753 0.79 CES2 (0.57) PARP1NPC1MAPTRELARAB9A
SCHEMBL30641511 0.79 CES2 (0.57) PARP1NPC1MAPTRELARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210115007-A1 STREPTOCOCCUS MUTANS GLUCOSYL TRANSFERASE INHIBITORS FOR DENTAL CARIES THERAPY NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-04-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210115007-A1 STREPTOCOCCUS MUTANS GLUCOSYL TRANSFERASE INHIBITORS FOR DENTAL CARIES THERAPY UGGT1, UGCG, GLA CHRNA7 4756/4885P4HB 2712/4885NR1H4 4098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback